Clarification of factors associated with post-artesunate delayed hemolysis (PADH): Analysis of 327 patients with severe imported Plasmodium falciparum malaria in France
Background: Post-Artesunate delayed hemolysis (PADH) occurs in approximately 15 % of treated patients 2–3 weeks after artesunate administration. Identifying risk markers for PADH would help predict which patients are at higher risk. Methods: In this prospective national cohort study conducted in a n...
Saved in:
Main Authors: | Pierre-Louis Conan, Marc Thellier, Eric Kendjo, Sandrine Houzé, Rémonie Seng, Stéphane Jauréguiberry |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Travel Medicine and Infectious Disease |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1477893925000079 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiac Arrhythmia in a Patient with Sickle Cell Anemia and Falciparum Malaria Treated with Intravenous Artesunate
by: Abdulrahman Hummadi, et al.
Published: (2019-01-01) -
The Immunological Plasmodium falciparum Malaria Characteristics of Children in Tajikistan Republic
by: Nighina M. Khodzhaeva, et al.
Published: (2019-01-01) -
On the estimation of sequestered infected erythrocytes in Plasmodium falciparum malaria patients
by: Derdei Bichara, et al.
Published: (2014-02-01) -
Relative Susceptibilities of ABO Blood Groups to Plasmodium falciparum Malaria in Ghana
by: Richmond Afoakwah, et al.
Published: (2016-01-01) -
Severe Case of Plasmodium falciparum Malaria in a Pregnant Woman from Nigeria
by: Kruti Yagnik, et al.
Published: (2019-01-01)